HGH and HBL – Trading Halt of Securities

HALT
Mon, Apr 08 2024 08:42 am

Memorandum

To: Market Participants
From: NZ RegCo
Date: Monday, 8 April 2024
Subject: Heartland Group Holdings Limited (“HGH”) and Heartland Bank Limited (“HBL”) – Trading Halt of Securities


Message:

NZ RegCo has approved a trading halt application from Heartland Group Holdings Limited (“HGH”). Trading in HGH’s ordinary shares and its subsidiary HBL’s quoted notes (“HBL1T2”) will be halted pre-market open today. Further to the announcement released on 20 March 2024, HBL’s quoted 3.55% fixed rate bonds (“HBL020”) are already suspended pending the maturity of those bonds.

Attached is the trading halt application, for further information.

Please contact NZX Product Operations on +64 4 496 2853 or [email protected] with any queries.

ENDS


Announcement PDF


Markets News

Fisher & Paykel Healthcare drives sharemarket up
Markets Market Close

Fisher & Paykel Healthcare drives sharemarket up

The S&P/NZX 50 Index closed up 0.61% or 81.576 points to 13,562.01.

Markets

Rakon stock-price climbs ahead of result

Rakon shares rose almost 9% on Wednesday but spiked even higher during the day.

Rakon stock-price climbs ahead of result
Markets

Fisher Funds backs Summerset in rejecting covenant waiver claims

Summerset is compliant with all lending covenants and obligations.

Fisher Funds backs Summerset in rejecting covenant waiver claims